PubMed · 3974645
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1985-03-14. Passive smoking.. https://doi.org/10.1056/nejm198503143121111
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Physiologically based pharmacokinetic (PBPK) models have been developed describing the disposition kinetics of nicotine and its major metabolite, cotinine, in man. Separate 9-compartment, flow-limited PBPK models were initially created for nicotine and cotinine. The physiological basis for compartment designation and parameter selection has been provided; chemical-specific tissue-to-blood partition coefficients and elimination rates were derived from published human and animal data. The individual models were tested through simulations of published studies of nicotine and cotinine infusions in man using similar dosing protocols to those reported. Each model adequately predicted the time course of nicotine or cotinine concentrations in the blood and urine following the administration of nicotine or cotinine. These individual models were then linked through the liver compartments to form a nicotine-cotinine model capable of predicting the metabolic production and disposition of cotinine from administered nicotine. The potential for integrating this functional PBPK model with an appropriate pharmacodynamic model for the characterization of nicotine's physiological effects is discussed.
Until now mass media smoking cessation studies have relied almost exclusively on self-reports of smoking cessation because biochemical confirmation has not seemed practical. This study investigated the reliability of mailed salivary cotinine specimens for the determination of smoking status. Two simultaneous saliva specimens were obtained from 10 smokers and 10 nonsmokers. One of each pair was frozen immediately. The other was sent through the local U.S. mail and then subjected to additional physical agitation and heat before being frozen. All specimens were subsequently analyzed for cotinine. No cotinine was detectable in any of the nonsmokers' specimens. There was excellent correlation between the paired smokers' specimens. These results show that the mailing of saliva specimens for cotinine analysis is practical and provides accurate data on smoking status. It is an approach which could easily be used in mass media smoking cessation studies to biochemically confirm smoking behavior.
The effect of cigarette smoking on salivary eicosanoid levels was investigated in 10 smoker and 10 non-smoker volunteers. The smokers consumed an average of 20 cigarettes/day for the past 5 years or longer. The smoking status was validated by salivary cotinine level. Eicosanoids were extracted from saliva with ethanol, and the radioimmunoassay was performed to determine the concentrations of four major eicosanoids, i.e. prostaglandin E2 (PGE2), PGF2 alpha, 6-sulphidopeptide-containing leukotrienes (LTs) and 12-hydroxyeicosatetraenoic acid (12-HETE). The levels of PGE2, PGF2 alpha, and LTs were significantly lower in the saliva of smokers as compared to that of the non-smokers (1.74 +/- 0.32 vs 2.41 +/- 0.64, p = 0.006; 0.36 +/- 0.12 vs 0.54 +/- 0.18, p = 0.04; 2.24 +/- 0.96 vs 4.92 +/- 1.29, p = 0.006; mean +/- SD, ng/ml saliva). No significant differences were found in the levels of 12-HETE between the two groups. The results suggest that cigarette smoking reduces the concentrations of both the cyclooxygenase and 5-lipoxygenase products in saliva.